|
PAF. See Platelet-activating factor
Pain. See also Anesthetics; Neuralgia
facial. (See Facial pain)
headache. (See Headaches)
ophthalmoplegias. (See Ophthalmoplegia, painfulin)
Pallor
optic disc. (See Optic disc, pallorof)
PALs. See Progressive addition lenses (PALs)
Palsy. See also Paralysis
Panretinal photocoagulation
Papillomavirus. See Human papillomavirus (HPV)
Paralysis. See also Palsy, of cranial nerves
Landry’s ascending. (See Guillain-Barre syndrome, bulbar variant)
Paramedian pontine reticular formation. See Pontine paramedian reticular formation
Paranasal sinuses
infection. (See Sinusitis)
Parinaud dorsal midbrain syndrome
PE. See Pigment epithelium
Pediatric migraine, 45
Pediatric neuro-ophthalmology, (Clinical Volume 2, Chapter 13)
acquired visual loss in childhood, 16–20
blind infant, 9–16
congenital motor anomalies, 20–35
Duane’s retraction syndrome, 21–25
elevator deficiencies, 27–29
Marcus Gunn jaw-winking synkineses, 29–32
Mobius syndrome, 25–27
orbital mechanics, 20–32
restrictive syndromes, 32
Brown tendon sheath syndrome, 32–34
congenital fibrosis syndromes, 34–35
vertical retraction syndrome, 29
functional visual loss, 62–65
headache in children, 44–46
pediatric migraine, 45
pediatric pseudotumor cerebri, 45–46
myasthenia gravis in childhood, 49–50
nystagmus, related disorders, 35–42
congenital nystagmus, 36–38
congenital ocular motor apraxia, 40–41
dyslexia, 42–44
Heimann-Bielschowsky phenomenon, 39–40
latent nystagmus, 38
ocular flutter/opsoclonus, 41–42
periodic alternating nystagmus, 39
spasmus nutans, 41
transient idiopathic nystagmus of infancy, 35
ocular motor cranial neuropathies, 46–49
ocular torticollis, 61–62
symptomatic sensory, nonparetic strabismic abnormalities, 50–51
accommodative effort syndrome, 61
convergence insufficiencies, 60–61
esotropia, acquired, 57–59
acute acquired comitant estropia, 57–58
cyclic esotropia, 58–59
divergence insufficiency estropia, 58
progressive estropia with nyopia, 59
failure of fusional mechanisms, 53–57
acquired central defects, 53–55
acquired visual loss, 56–57
congenital anomalies, 55–56
problems at near, 60–61
visual development, 8–9
Pediatric ophthalmology. See also Infants
neuroblastoma in. ( See also Neuroblastoma)
retinoblastoma. (See Retinoblastoma)
rheumatoid arthritis, juvenile. (See Rheumatoid arthritis, juvenile (Still’s disease))
xanthogranuloma in. (See Xanthogranuloma, juvenile)
Pediatric pseudotumor cerebri, 45–46
Penbriten. See Ampicillin
Penetrating keratoplasty. See Keratoplasty, penetrating
Penetrating trauma. See Trauma, penetrating
Penthrane. See Methoxyflurane (Penthrane)
Peptides. See also specific peptides
Perforations
corneal. (See Cornea, perforations)
globe. (See Globe, perforating injury)
Perfusion pressure. See Blood pressure
PERG. See Pattern electroretinogram (PERG)
Periaqueductal syndrome. See Parinaud’s dorsal midbrain syndrome
Periarteritis nodosa. See Polyarteritis nodosa
Peripheral neurofibromatosis. See Neurofibromatosis
Persistent fetal vasculature, angle-closure glaucoma and, 11, 12
Persistent hyperplastic primary vitreous (PHPV). See Vitreous, primary, persistent hyperplasia
Perspex CQ. See Polymethylmethacrylate (PMMA)
PET scanning. See Positron emission tomography
PGI2. See Prostacyclin
Phacofragmentation. See Phacoemulsification
Phacolytic glaucoma. See Glaucoma, phacolytic
Phacomorphic glaucoma. See Glaucoma, phacomorphic
Pharmacology. See also Drugs
Phenergan. See Promethazine
Phenylacetic acids. See Nonsteroidal anti-inflammatory drugs (NSAIDs)
Phenylalkanoic acids. See Nonsteroidal anti-inflammatory drugs (NSAIDs)
Phenytoin sodium (Dilantin)
Phlebitis, retinal. See also Retinal vasculitis
PHMB (polyhexamethyl biguanide). See Polyhexanide
Phoria
vertical, induced with bifocals, correction
Phospholine Iodide. See also Echothiophate iodide (Phospholine Iodide)
Photoablation. See also Ablation
Photocoagulation
in retinal vein occlusion
Photography
fundus. (See Fundus, photography; Fundus cameraof)
Photopigments. See Pigment(s)
Photoreceptor(s), retinal, 2–6. See also Cones; Rods; (Clinical Volume 2, Chapter 2) (Clinical Volume 2, Chapter 4) (Clinical Volume 3, Chapter 1) (Foundations Volume 2, Chapter 13)
“dark current, ”, (2) 13: 3
degeneration
progressive. (See Retinitis pigmentosa)
outer plexiform layer. (See Outer plexiform layer (OPL))
scotopic vision, (1)33: 25in
triads, (3)1: 9, 10
Phototoxicity. See also Light toxicity
PHPV (persistent hyperplastic primary vitreous). See See Vitreous, persistent hyperplastic primary; Vitreous, primary, persistent hyperplasia
Phycomycosis. See Mucormycosis (phycomycosis)
Phytanic acid storage disease. See Refsum’s disease
Pigmentary retinopathies. See Retinopathy, pigmentary
Pigment epithelium, retinal. See Retinal pigment epithelium
Pigment(s). See also specific pigments
Pilocar. See Pilocarpine
Pilocel. See Pilocarpine
Pimaricin. See Natamycin
Piroxicam. See Nonsteroidal anti-inflammatory drugs (NSAIDs)
Placidyl. See Ethchlorvynol
Placoid pigment epitheliopathy
Plain roentgenogram evaluation of orbital disease. See Orbital disease, plain roentgenogram evaluation of
Plastic implants. See Implants
Plastic surgery. See Reconstructive surgery
Platelet aggregation, inhibitors. See Antiplatelet agents
Platybasia. See Basilar impressions of skull
Pleomorphic rhabdomyosarcoma. See Rhabdomyosarcoma
Plica lacrimalis. See Valve of Hasner
PMNs. See Leukocytes, polymorphonuclear
PMR. See Polymyalgia rheumatica
POHS. See Presumed ocular histoplasmosis syndrome
Poikiloderma congenitale. See Rothmund’s syndrome
Polydystrophic dwarfism. See Maroteaux-Lamy syndrome
Polydystrophic oligophrenia. See Sanfilippo syndrome
Polyhexamethyl biguanide (PHMB). See Polyhexanide
Polymethylmethacrylate (PMMA)
Polymorphic vitelliform macular dystrophy. See Best’s vitelliform dystrophy
Polymorphous dystrophy, posterior
Polytrim. See Trimethoprim/polymyxin B sulfate
Pompe disease. See Glycogen storage disease
PORN. See Progressive outer retinal necrosis
Posner-Schlossman syndrome. See Glaucomatocyclitic crisis
Posterior chamber intraocular lens. See also Intraocular lenses
Posterior corneal defect. See Peters’ anomaly
Posterior embryotoxon, (1)53: 15
Posterior polymorphous dystrophy
Posterior segment of eye. See also specific structure
Posterior uveitis. See Uveitis, posterior
Povidone-iodine
prophylaxis
endophthalmitis, (4)55: 7–8for
Power
optical. (See Optical power)
PPE. See Personal protective equipment
PPRF. See Pontine paramedian reticular formation
Prednisone. See also Corticosteroid therapy
Premacular gliosis. See Epiretinal membranes
Prematurity
retinopathy of. (See Retinopathy of prematurity (retrolental fibroplasia))
Preretinal retraction. See Vitreoretinopathy, proliferative
Pressure
in glaucomatolytic crisis
measurements. (See Tonography; Tonometry)
tonography. (See Tonography, in glaucoma)
intracranial. (See Intracranial pressure increase)
intraocular. (See Intraocular pressure)
Presumed ocular histoplasmosis syndrome (POHS), (3) 13: 26–27; 38: 13; See also Histoplasmosis
Preventive ophthalmology. See Geographic and preventive ophthalmology
Progressive external ophthalmoplegia. See Ophthalmoplegia, progressive external
Progressive systemic sclerosis. See Scleroderma
PROMM. See Proximal myotonic myopathy
Propine. See Dipivefrin
Propranolol. See also Beta-adrenergic antagonists
Proptosis. See also Exophthalmos
Prostaglandins
inhibitors. (See Nonsteroidal anti-inflammatory drugs (NSAIDs))
Prostaglandin synthesis inhibitors
Prosthesis. See Implants; Keratoprosthesis
Prosthokeratoplasty. See Keratoplasty; Keratoprosthesis
Protein(s). See also specific proteins
Protopam. See Pralidoxime
Provisc. See Viscoelastic materials
Pseudoglioma. See also Persistent hyperplastic primary vitreous (PHPV); Retrolental fibroplasia (RLF)
Pseudoinflammatory macular dystrophy, (1)60: 8
Pseudophakia
intraoperative lens implantation in
Pseudosarcomatous fasciitis. See Fasciitis, nodular
Pseudotumor cerebri, pediatric, 45–46
Pseudotumors
superior orbital fissure and cavernous sinus. (See Tolosa-Hunt syndromein)
Psychophysics
eye movements. (See Ocular motility, psychophysics ofof)
Pteroylglutamic acid. See Folic acid
PTFE. See Polytetrafluoroethylene (PTFE)
PTU. See Propylthiouracil (PTU)
Public health. See Epidemiology
Pulmonary disorders. See Lung disease
Pupillary membrane
persistent, (1)53: 18
“Pure” microphthalmos. See Nanophthalmia
Purtscher-like retinopathy
PUVA therapy. See Psoralen-ultraviolet A (PUVA) therapy
PVEP. See Pattern visual evoked potential
Pyrazolones. See Nonsteroidal anti-inflammatory drugs (NSAIDs)
Back to Top
|